Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. is projected to experience a normalized funds from operations per share (FFOps) growth of 6.7% in 2025, with continued growth estimated at 2.9% in 2026 and an impressive 7.9% annual growth forecasted over the next five years. The company stands to benefit from potential rent increases upon upcoming lease expirations, particularly within its skilled nursing segment, which could serve as a positive catalyst for revenues. Additionally, despite third-quarter performance slightly falling short of expectations for the Senior Housing Operating Portfolio (SHOP), the overall fundamentals remain strong, supported by a robust pipeline of accretive investment opportunities.

Bears say

National Health Investors Inc faces several risks that contribute to a negative outlook, particularly related to the anticipated lower rent reset from NHC and potential challenges in deferred rent collections. The company has adjusted its 2026 funds from operations (FFO) estimates downward, now projecting $5.00 per share compared to a previous estimate of $5.09 per share, reflecting more conservative assumptions regarding net investments. Additionally, the possibility of operators encountering difficulties—potentially stemming from external factors such as pandemics—further exacerbates concerns about the stability and reliability of revenue streams.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.